Firm Tests New Cancer Treatment With Reduced Side-Effects
Posted on: Tuesday, 21 February 2006, 06:00 CST
A HEALTHCARE group yesterday unveiled plans to test a new chemotherapy treatment for cancer that it claims could markedly reduce unwanted side-effects such as nausea and hair-loss.
Ark Therapeutics has developed Scavidin, a version of a naturally occurring molecule called avidin, which recognises the cancer- fighting drug used in radiotherapy and chemotherapy and then "shuttles" it back and forth in the body, picking up the cancer drugs and taking them to the heart of the tumour.
The Anglo-Finnish firm said it meant that tumour development could be halted by using just one tenth of the conventional chemotherapy dose.
Ark said initial laboratory tests showed the treatment eliminated tumour growth in seven to 10 days, while non-treated tumours grew three to five times the size in the same period. No side-effects were observed. Chief executive officer Nigel Parker said the potential market for the gene-based technology was "very large".
Source: Daily Post; Liverpool
Related Articles
- Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models
- Retrospective Analysis Finds Treatment of Cancer Chemotherapy Patients With Epoetin Alfa Associated With Lower Drug Cost Than Darbepoetin Alfa
- Technique Images Tumor Vessel Leakiness to Predict Breast Cancer Chemotherapy Outcome
- Valeant Pharmaceuticals Files Investigational New Drug Application for Cesamet(R) in Cancer Chemotherapy-Induced Neuropathic Pain
- Novacea's Phase 1 Data of Asentar Published in the Journal of Cancer Chemotherapy and Pharmacology
- Valeant Pharmaceuticals Announces Availability of Complimentary ``Managing Chemotherapy Side Effects For Dummies'' Cancer Chemotherapy Resource; Special Edition ``For Dummies''(R) Book Now Available for Cancer Chemotherapy Patients and Caregivers
- MultiVu Video Feed: FDA Approves Cesamet to Treat Nausea and Vomiting Associated With Cancer Chemotherapy
- Many Stop Colon-Cancer Chemotherapy
- The Pharmacogenomics of Anti-Cancer Chemotherapy
- BioVex Announces That the Efficacy of Cancer Chemotherapy is Enhanced When Used in Combination With OncoVEX in Pre-Clinical Models
 |
 |
User Comments (0)
RSS Feeds